BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 20138935)

  • 1. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
    Makhlof A; Werle M; Tozuka Y; Takeuchi H
    J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
    Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
    Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
    Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
    Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
    Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
    Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
    Thanou M; Henderson S; Kydonieus A; Elson C
    J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles.
    Liu Y; Di Zang H; Kong M; Ma FK; Dang QF; Cheng XJ; Ji QX; Chen XG
    Carbohydr Polym; 2012 Jun; 89(2):453-60. PubMed ID: 24750743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
    Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
    Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
    Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
    Gupta V; Hwang BH; Doshi N; Mitragotri S
    J Control Release; 2013 Dec; 172(2):541-9. PubMed ID: 23680288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug.
    Fabiano A; Piras AM; Uccello-Barretta G; Balzano F; Cesari A; Testai L; Citi V; Zambito Y
    Eur J Pharm Biopharm; 2018 Sep; 130():281-289. PubMed ID: 30006244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
    Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S
    J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labrasol
    Heade J; Maher S; Bleiel SB; Brayden DJ
    J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
    Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
    Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
    J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption-enhancing effects of gemini surfactant on the intestinal absorption of poorly absorbed hydrophilic drugs including peptide and protein drugs in rats.
    Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Int J Pharm; 2016 Feb; 499(1-2):58-66. PubMed ID: 26707414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery.
    Sajeesh S; Bouchemal K; Sharma CP; Vauthier C
    Eur J Pharm Biopharm; 2010 Feb; 74(2):209-18. PubMed ID: 19737614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of SPM-NONOate following intrapulmonary delivery in promoting absorptions of poorly absorbed macromolecules in rats and the underling mechanism.
    Gao Y; Liao G; Wang S; Sun Y; Long X; Ma Y; Zhang H
    Int J Pharm; 2020 Mar; 577():119044. PubMed ID: 31954866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stabilized thiomer PAA-Cys-6MNA].
    Yang JS; Chen XH; Zhang H; Dai WB; Wang XQ; Zhang Q
    Yao Xue Xue Bao; 2014 Jun; 49(6):942-8. PubMed ID: 25212045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
    Dong Z; Katsumi H; Sakane T; Yamamoto A
    Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitated nanoscale delivery of insulin across intestinal membrane models.
    Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
    Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.